Inhibitor development refers to the body's immune response against certain therapeutic agents, such as clotting factor concentrates used in hemophilia treatment. Inhibitors are antibodies that neutralize the effectiveness of these therapeutic agents, rendering them ineffective. This is a significant challenge in managing conditions like hemophilia, as it complicates treatment and increases the risk of bleeding episodes.
